NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
    • Research Themes Overview
    • Cancer
    • Cardiovascular Medicine
    • Digital Health from Hospital to Home
    • Gene and Cell Therapy
    • Genomic Medicine
    • Imaging
    • Inflammation across Tissues
    • Life-saving Vaccines
    • Metabolic Experimental Medicine
    • Modernising Medical Microbiology and Big Infection Diagnostics
    • Musculoskeletal
    • Preventive Neurology
    • Respiratory Medicine
    • Surgical Innovation, Technology and Evaluation
    • Translational Data Science
  • Patient & Public Involvement
    • Getting involved with research
    • View and register for involvement opportunities
    • Patient & Public Groups
    • Patient and Public Involvement Advisory Group
    • Diversity in Research Group
    • Oxford Blood Group
    • Case Studies
    • PPIE Strategy
    • PPIE News
    • PPI Researcher Guidance
    • Researchers: Post a PPIE opportunity
  • Training Hub
    • Training Hub Overview
    • Clinical Academic Pathway
    • Internships
    • Preparatory Research Fellowships
    • Senior Research Fellowships
    • Research Training Bursaries
    • Doctoral Awards
    • Post-Doctoral Awards
    • Other funding
    • Leadership Training
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • Who Do We Work With?
    • Events
    • Further Information and Additional Resources
    • Contacts for Industry
  • Videos
  • News
  • Events

News Archive

You are here: Home > News > News for COVID-19

COVID-19 News

New computational technique reveals changes to lung function after COVID-19 infection

5 October 2022 · Listed under COVID-19, Respiratory Medicine

A study led by Oxford researchers has found that prior COVID-19 infection is associated with more uneven inflation of the lungs during normal breathing. There was also an association between hospitalisation with COVID-19 and smaller lung volumes, and admission to the intensive care unit (ICU) was ... READ MORE

Study develops radiotranscriptomic AI analysis to enable virtual heart biopsies

5 September 2022 · Listed under Cardiovascular Medicine, COVID-19, Imaging

Oxford University researchers have found a new way of directly quantifying vascular inflammation in COVID-19 patients, in a study that could pave the way to more efficient trials of new treatments and identify patients who might be at risk of long-term complications.  The study, which was ... READ MORE

Higher risk of blood clots in COVID-19 outpatients, largely reduced after vaccination

22 August 2022 · Listed under COVID-19, Gene and Cell Therapy, Translational Data Science

Researchers supported by the NIHR Oxford Biomedical Research Centre (BRC) have studied the link between people diagnosed with COVID-19 as outpatients and the short-term risk of developing blood clots, and the clinical and genetic risk factors that predispose them to developing post–COVID-19 ... READ MORE

COVID-19 vaccine protects people of all body weights from hospitalisation and death

1 July 2022 · Listed under COVID-19, Obesity, Diet and Lifestyle

Two doses of the COVID-19 vaccine are effective against severe disease for people who are underweight, overweight, or who have obesity, new research by University of Oxford researchers has found. Obesity was flagged as a risk factor for severe COVID-19 early in the global pandemic. The UK’s ... READ MORE

Study highlights ongoing COVID-19 risk in some cancer patients despite vaccination

24 May 2022 · Listed under Cancer, COVID-19

A study has found that while COVID-19 vaccination is effective in most cancer patients, the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly. The study, published in ... READ MORE

OUH agrees long COVID research collaboration with Polarean

11 May 2022 · Listed under COVID-19, Imaging, Respiratory Medicine

Oxford University Hospitals (OUH) and the medical imaging technology company, Polarean Imaging plc, have entered into a research collaboration to study the long-term effects of COVID-19 in patients who are still experiencing breathlessness months after infection.  Polarean produce an ... READ MORE

Study finds no increased risk of rare neurological events after COVID vaccination

17 March 2022 · Listed under COVID-19, Musculoskeletal, Preventive Neurology

A study of more than eight million people has found no increased risk of rare neurological events after COVID -19 vaccination. However, the researchers did find a higher risk of Bell’s palsy (facial weakness), encephalomyelitis (inflammation of the brain and spinal cord) and Guillain-Barré ... READ MORE

Blog: Developing a process to monitor populations at increased risk from coronavirus

11 March 2022 · Listed under COVID-19, Modernising Medical Microbiology and Big Infection Diagnostics

Emma Pritchard is a Medical Statistician in the Modernising Medical Microbiology team at the John Radcliffe Hospital in Oxford. She works in the Oxford BRC’s Antimicrobial Resistance and Modernising Microbiology Theme. In this blog, Emma explains how she used the ongoing Office for National ... READ MORE

Brain regions related to smell show decline after mild COVID-19

7 March 2022 · Listed under COVID-19, Preventive Neurology, Translational Data Science

University of Oxford researchers have found tissue damage and greater shrinkage in brain areas related to smell in people following mild SARS-CoV-2 infection. The researchers, who were supported by the NIHR Oxford Biomedical Research Centre (BRC) used data from UK Biobank participants to look ... READ MORE

RECOVERY trial finds another drug to treat hospitalised COVID-19 patients

3 March 2022 · Listed under COVID-19, Translational Data Science

The RECOVERY Trial, the world’s largest randomised trial of potential COVID-19 treatments, has found another drug that reduces the risk of death in hospitalised patients with the disease. The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial showed that baricitinib, ... READ MORE

NIHR highlights QCOVID role in tackling pandemic

2 March 2022 · Listed under COVID-19, Multimorbidity and Long-Term Conditions, Translational Data Science

The National Institute for Health Research (NIHR) has published a case study on QCOVID, a clinical risk prediction model, which has played a key role during the COVID-19 pandemic in identifying those people at greatest risk. QCOVID, developed with support from the NIHR Oxford Biomedical Research ... READ MORE

Oxford BRC’s ability to deliver rapid COVID-19 research response highlighted

22 February 2022 · Listed under COVID-19, Life-saving Vaccines, Translational Data Science

Oxford Biomedical Research Centre (BRC) researchers have highlighted how the BRC’s infrastructure gave it the agility and capacity to respond rapidly with research projects to tackle COVID-19. In a commentary published in the open access BMC Health Research Policy and Systems journal, the ... READ MORE

COVID-19 blog: accelerating testing with robotics

21 February 2022 · Listed under COVID-19, Modernising Medical Microbiology and Big Infection Diagnostics

PhD student Kevin Chau, who works in the Oxford BRC’s Antimicrobial Resistance and Modernising Microbiology Theme, has played his part in the pandemic response as part of the Modernising Medical Microbiology team at the John Radcliffe Hospital in Oxford. In this blog post written for the Medical ... READ MORE

Review highlights impact of Long COVID on cardiovascular system

18 February 2022 · Listed under Cardiovascular Medicine, COVID-19, Imaging

The wide-ranging effects of long COVID and the associated issues for healthcare providers have been revealed in a new review of the major studies into the condition, which specifically highlights the impact of long COVID on the cardiovascular system. The review, published in the European Heart ... READ MORE

Lung abnormalities found in long COVID patients with breathlessness

29 January 2022 · Listed under COVID-19, Imaging

Researchers have identified abnormalities in the lungs of long COVID patients who are experiencing breathlessness that cannot be detected with routine tests. The EXPLAIN study, which involves teams in Oxford, Sheffield, Cardiff and Manchester, is using hyperpolarised xenon MRI scans to ... READ MORE

Drug could more effectively treat patients hospitalised with COVID-19 pneumonia, research finds

17 December 2021 · Listed under COVID-19, Musculoskeletal

A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia. The CATALYST Trial tested the rheumatoid arthritis treatment namilumab as a potential therapeutic to treat patients who are hospitalised with COVID-19 ... READ MORE

People with long COVID after hospitalisation face limited recovery after one year

16 December 2021 · Listed under COVID-19, Imaging, Respiratory Medicine

People who were hospitalised with COVID-19 and continued to experience symptoms five months later show limited further recovery one year after hospital discharge, according to the latest results of a major national study looking at the long-term health impacts of COVID-19 on hospitalised ... READ MORE

COVID-19 infection more likely than vaccines to cause rare cardiovascular complications

14 December 2021 · Listed under COVID-19, Life-saving Vaccines, Translational Data Science

Researchers have reported the results of the largest ever study to compare the risks of cardiovascular events - such as myocarditis, pericarditis, and cardiac arrhythmia - between different vaccines and COVID-19 infection, and the first to investigate the association between cardiac events and the ... READ MORE

RECOVERY Trial launched in South Africa

9 December 2021 · Listed under COVID-19, Translational Data Science

The world’s largest clinical trial investigating treatments for COVID-19 has now been launched in South Africa, with the first patient recruited today. Since March 2020, the RECOVERY Trial, which is supported by the NIHR Oxford BRC, has discovered three effective treatments for COVID-19: the ... READ MORE

Study uncovers gene that doubles risk of death from COVID-19

5 November 2021 · Listed under COVID-19, Genomic Medicine

University of Oxford researchers have identified the gene responsible for doubling the risk of respiratory failure from COVID-19. Sixty percent of people with South Asian ancestry carry the high-risk genetic signal, which could partly explain the excess deaths seen in some UK communities, ... READ MORE

  • 1
  • 2
  • 3
  • …
  • 7
  • Next Page »

Other News

News Categories

News by Month

See all news

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2023 NIHR Oxford Biomedical Research Centre